Nunzia Pharmaceutical Company filed its 10-K/A on Mar 29, 2022 for the period ending Dec 31, 2020. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.3M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- NUNZ Stock
- News Nunzia Pharmaceutical Company
- Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt